Central Trust Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Sell |
20,519
-305
| -1% | -$166K | 0.2% | 86 |
|
|
2025
Q4 | $12.1M | Sell |
20,824
-247
| -1% | -$140K | 0.24% | 74 |
|
|
2025
Q3 | $10.2M | Sell |
21,071
-1,080
| -5% | -$503K | 0.21% | 81 |
|
|
2025
Q2 | $8.98M | Sell |
22,151
-1,823
| -8% | -$762K | 0.21% | 86 |
|
|
2025
Q1 | $11.9M | Sell |
23,974
-1,615
| -6% | -$875K | 0.29% | 65 |
|
|
2024
Q4 | $13.3M | Sell |
25,589
-180
| -0.7% | -$99K | 0.33% | 61 |
|
|
2024
Q3 | $15.9M | Sell |
25,769
-255
| -1% | -$151K | 0.37% | 57 |
|
|
2024
Q2 | $14.4M | Sell |
26,024
-198
| -0.8% | -$113K | 0.35% | 57 |
|
|
2024
Q1 | $15.2M | Sell |
26,222
-75
| -0.3% | -$42.1K | 0.38% | 54 |
|
|
2023
Q4 | $14M | Buy |
26,297
+24
| +0.1% | +$11.6K | 0.37% | 55 |
|
|
2023
Q3 | $13.3M | Sell |
26,273
-181
| -0.7% | -$96.5K | 0.38% | 52 |
|
|
2023
Q2 | $13.8M | Sell |
26,454
-87
| -0.3% | -$46.9K | 0.39% | 55 |
|
|
2023
Q1 | $15.3M | Sell |
26,541
-391
| -1% | -$220K | 0.45% | 50 |
|
|
2022
Q4 | $14.8M | Sell |
26,932
-1,839
| -6% | -$974K | 0.46% | 48 |
|
|
2022
Q3 | $14.6M | Sell |
28,771
-235
| -0.8% | -$132K | 0.5% | 44 |
|
|
2022
Q2 | $15.8M | Sell |
29,006
-2,062
| -7% | -$1.13M | 0.52% | 45 |
|
|
2022
Q1 | $18.4M | Sell |
31,068
-1,111
| -3% | -$638K | 0.53% | 41 |
|
|
2021
Q4 | $21.5M | Buy |
32,179
+502
| +2% | +$313K | 0.61% | 37 |
|
|
2021
Q3 | $18.1M | Buy |
31,677
+289
| +0.9% | +$159K | 0.65% | 36 |
|
|
2021
Q2 | $15.8M | Sell |
31,388
-1,552
| -5% | -$732K | 0.57% | 43 |
|
|
2021
Q1 | $15M | Buy |
32,940
+2,649
| +9% | +$1.26M | 0.59% | 42 |
|
|
2020
Q4 | $14.1M | Buy |
30,291
+278
| +0.9% | +$130K | 0.58% | 40 |
|
|
2020
Q3 | $13.3M | Sell |
30,013
-50
| -0.2% | -$20.7K | 0.6% | 41 |
|
|
2020
Q2 | $10.9M | Sell |
30,063
-957
| -3% | -$321K | 0.55% | 45 |
|
|
2020
Q1 | $8.8M | Buy |
31,020
+1,505
| +5% | +$475K | 0.54% | 45 |
|
|
2019
Q4 | $9.59M | Buy |
29,515
+255
| +0.9% | +$77.3K | 0.49% | 50 |
|
|
2019
Q3 | $8.52M | Buy |
29,260
+113
| +0.4% | +$32.4K | 0.48% | 50 |
|
|
2019
Q2 | $8.61M | Sell |
29,147
-719
| -2% | -$198K | 0.49% | 50 |
|
|
2019
Q1 | $8.18M | Buy |
29,866
+640
| +2% | +$159K | 0.49% | 49 |
|
|
2018
Q4 | $6.54M | Buy |
29,226
+1,509
| +5% | +$354K | 0.43% | 54 |
|
|
2018
Q3 | $6.76M | Buy |
27,717
+607
| +2% | +$140K | 0.39% | 59 |
|
|
2018
Q2 | $5.62M | Buy |
27,110
+204
| +0.8% | +$43.3K | 0.36% | 65 |
|
|
2018
Q1 | $5.55M | Buy |
26,906
+686
| +3% | +$144K | 0.35% | 64 |
|
|
2017
Q4 | $4.98M | Sell |
26,220
-1,650
| -6% | -$316K | 0.3% | 82 |
|
|
2017
Q3 | $5.27M | Sell |
27,870
-2,603
| -9% | -$471K | 0.34% | 73 |
|
|
2017
Q2 | $5.32M | Buy |
30,473
+299
| +1% | +$50.2K | 0.35% | 75 |
|
|
2017
Q1 | $4.63M | Buy |
30,174
+2,100
| +7% | +$321K | 0.31% | 90 |
|
|
2016
Q4 | $3.96M | Buy |
28,074
+5,130
| +22% | +$756K | 0.27% | 99 |
|
|
2016
Q3 | $3.65M | Buy |
22,944
+736
| +3% | +$113K | 0.27% | 102 |
|
|
2016
Q2 | $3.28M | Buy |
22,208
+165
| +0.7% | +$24.4K | 0.25% | 105 |
|
|
2016
Q1 | $3.12M | Buy |
22,043
+4,239
| +24% | +$568K | 0.25% | 102 |
|
|
2015
Q4 | $2.52M | Buy |
17,804
+2,565
| +17% | +$342K | 0.21% | 116 |
|
|
2015
Q3 | $1.86M | Buy |
15,239
+1,644
| +12% | +$214K | 0.16% | 134 |
|
|
2015
Q2 | $1.76M | Buy |
13,595
+274
| +2% | +$35.7K | 0.14% | 154 |
|
|
2015
Q1 | $1.79M | Buy |
13,321
+4,065
| +44% | +$524K | 0.14% | 146 |
|
|
2014
Q4 | $1.16M | Buy |
9,256
+485
| +6% | +$59K | 0.09% | 181 |
|
|
2014
Q3 | $1.07M | Buy |
8,771
+3,808
| +77% | +$463K | 0.08% | 202 |
|
|
2014
Q2 | $586K | Buy |
4,963
+1,006
| +25% | +$118K | 0.05% | 279 |
|
|
2014
Q1 | $475K | Buy |
3,957
+490
| +14% | +$58.3K | 0.04% | 302 |
|
|
2013
Q4 | $386K | Sell |
3,467
-314
| -8% | -$31.2K | 0.03% | 331 |
|
|
2013
Q3 | $348K | Sell |
3,781
-19
| -0.5% | -$1.72K | 0.03% | 334 |
|
|
2013
Q2 | $321K | Buy |
+3,800
| New | +$316K | 0.03% | 322 |
|
Other funds holding TMO
VCM
Central Trust Company's TMO Position: Q1 2026 in Review
Central Trust Company reduced its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, selling an estimated $166K and leaving 20,519 shares worth $10.1M. The position accounts for 0.2% of the portfolio, ranked #86.
Central Trust Company first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.5M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Central Trust Company held 20,519 shares of Thermo Fisher Scientific worth $10.1M as of Q1 2026.
- Central Trust Company sold 305 Thermo Fisher Scientific shares in Q1 2026, an estimated $166K.
- Thermo Fisher Scientific made up 0.2% of Central Trust Company's portfolio in Q1 2026, its #86 holding.
- Central Trust Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Thermo Fisher Scientific position peaked at $21.5M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.